Last reviewed · How we verify
NCT04119180
Sedation Versus Protective Stabilization for Pediatric Dental Treatment
Phase 4 trial testing Ketamine 50 MG/ML in Child Behavior in 152 participants. Currently enrolling.
28 February 2025
Quick facts
| Lead sponsor | Universidade Federal de Goias |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 152 |
| Start date | 30 January 2020 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2026 |
| Sites | 2 locations across Brazil |
Drugs / interventions tested
- Ketamine 50 MG/ML — full drug profile →
- Midazolam Hcl 2Mg/Ml Syrup
- Protective stabilization
Conditions studied
- Child Behavior — all drugs for Child Behavior →
- Dental Caries in Children — all drugs for Dental Caries in Children →
Sponsor
Universidade Federal de Goias — full company profile →
Who can join
Adults 1 to 7, any sex, with Child Behavior or Dental Caries in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is a lack of evidence on the effectiveness of moderate sedation in pediatric dentistry, compared to protective stabilization, which remains routinely used in the Brazilian context despite moral questions. The objective of this prospective nonrandomized clinical trial is to evaluate the effectiveness of the use of moderate sedation, compared to the protective stabilization, in the dental care of children with fear / anxiety and / or dental behavior problem, and associated factors. The study will be carried out in outpatient clinics of the Dental Schools of the Federal University of Goiás (UFG) and University of São Paulo (USP), with the support of professors from King's College London through the partnership CEDACORE - Children Experiencing Dental Anxiety: Collaboration on Research and Education. Participants will be 152 children under 7 years of age with dental caries, who need specialized dental treatment due to a history of non-cooperation with dental care. The interventions to be compared are moderate sedation with oral administration of ketamine and midazolam (UFG) and protective stabilization (USP). The primary endpoint 'behavior / anxiety of the child during treatment will be assessed using the Ohio State University Behavioral Rating Scale. The secondary outcomes are: dental behavioral and anxiety evolution of the child, child' pain during procedure, impact on the quality of life related to oral health, parents and dentists' satisfaction and stress, adverse events for sedated participants, longevity of composite and glass ionomer cement restorations, chronotype and physiological stress of these children. A cost-efficacy analysis will be produced at the end of the study from the perspective of the Sistema Único de Saúde. Additionally, at the end of 36 months, the investigators expect to contribute to the identification of psychosocial aspects related to dental behavior problems in children in early childhood. It is important to highlight the perspective of technological innovation, with the creation of a digital platform that will allow the registration of data related to the dental care of children worldwide and favor analyzes in the methodology of data science.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sedation versus protective stabilization for dental treatment of children with caries and challenging behavior at the dentist (CHOOSE): a study protocol for a non-randomized clinical trial.
da Silva GS, Anabuki AA, Viana KA, Corrêa-Faria P, et al · · 2021 · cited 5× · PMID 33980232 · DOI 10.1186/s12903-021-01594-0
Verify or expand the search:
- PubMed search for NCT04119180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ketamine 50 MG/ML
Trials testing the same drug.
- NCT04938713 — Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome. · NA · unknown
- NCT04227704 — Ketamine to Prevent PPD After Cesarean · Phase 3 · completed
Other recruiting trials for Child Behavior
Currently open trials in the same condition.
- NCT07209696 — Storybook and Animation Video Adjuncts to Tell-Show-Do in Pediatric Dentistry · NA · active not recruiting
- NCT06586723 — Impact Trial of Helping Educational Leaders Mobilize Evidence · NA · recruiting
- NCT06341179 — Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep) · NA · recruiting
- NCT06084910 — Self-Concept Reinforcement for Early School Readiness · NA · recruiting
- NCT06163703 — Strengthening Child Social-Emotional and Lifestyle Health in Families Experiencing Stress · NA · active not recruiting
Other Universidade Federal de Goias trials
Trials by the same sponsor.
- NCT06636006 — Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia · NA · recruiting
- NCT04605016 — Clinical Performance of Dentals Implants With Hydrophilic or Hydrophobic Surfaces · NA · unknown
- NCT04760457 — Mandibular Overdentures Retained by Mini Implants: a Clinical Trial Comparing Different Surgical and Loading Protocols · NA · completed
- NCT06000280 — Evaluation of Retina in Patients With Glaucoma Using Topical Prostaglandins Undergoing Trabeculectomy Surgery · NA · completed
- NCT04691258 — Back Squat Exercise Treatment for Low Back Pain: Clinical Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04119180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Goias
- Last refreshed: 10 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing